Repligen Corporation (RGEN) Q4 2025 Earnings Results

Repligen Corp Beats on EPS, Stock Down 0.54%

Repligen's earnings report shows a positive surprise on EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.54%. This could suggest that investors were looking for more comprehensive revenue details or guidance, which were not provided.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.49	N/A	+11.36%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in the company's strategic direction. They emphasized their commitment to enhancing product offerings.

Management highlighted strong demand in the bioprocessing market.

They noted ongoing investments in innovation to drive future growth.

Repligen Corp Beats on EPS, Stock Down 0.54%

Key numbers

Management commentary

Repligen Corporation

More earnings this week

Repligen Corp Beats on EPS, Stock Down 0.54%

Key numbers

Management commentary